Clinical Trial Update: Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing tamoxifen alone versus tamoxifen with aminoglutethimide in postmenopausal receptor-positive early-stage breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aminoglutethimide (aminoglutethimide)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Early-stage Breast Cancer | Phase 3 | Status: COMPLETED